Top Markets
#1 Islamic Coin Islamic Coin +154.37%
#2 PulseChain PulseChain +51.62%
#3 BOOK OF MEME BOOK OF MEME +40.64%
#4 DogBull DogBull +34.45%
#5 Ergo Ergo +18.71%
#6 Nockchain Nockchain +18.33%
#7 ORDI ORDI +17.36%
#8 rsERG rsERG +16.41%
#9 RedStone RedStone +16.37%
#10 Victoria VR Victoria VR +15.68%
Coin of the day
Islamic Coin Islamic Coin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
TCR2 Therapeutics Inc. TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCRR
Pozycja w akcjach #27038
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on... TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on developing cutting-edge T cell receptor (TCR) therapies for cancer patients. The company's lead investigational treatment, gavo-cel, is a unique mono TCR Fusion Construct T cell (TRuC-T cell) designed to target mesothelin-positive solid tumors. This therapy is currently being evaluated in Phase I/II clinical trials for non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Furthermore, TCR2 Therapeutics has concluded preclinical development for TC-510, another TRuC-T cell specifically engineered to target mesothelin on solid tumors. They are also advancing TC-520, a CD70-targeting TRuC-T cell designed with fratricide resistance for treating renal cell carcinoma. Founded in 2015, the company, formerly known as TCR2, Inc. until its name change in November 2016, is headquartered in Cambridge, Massachusetts.
Cena akcji
$1.48
Ostatnia synchronizacja: 2023-05-31
Kapitalizacja rynkowa
$35.54M
Zmiana (1 dzień)
-5.73%
Zmiana (1 rok)
0.00%
Kraj
US
Handel TCR2 Therapeutics Inc. (TCRR)

Kategoria

Healthcare
Historia ceny akcji dla TCR2 Therapeutics Inc. (TCRR)
Najwyższa cena zamknięcia: $1.83 dnia 2023-05-01

Najniższa cena zamknięcia: $16.51 dnia 2019-02-01
Historia cen akcji firmy TCR2 Therapeutics Inc. od 2019 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 73.43%
2022 -78.52%
2021 -83.60%
2020 79.84%
2019 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $552.07 39.99%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $168.77 527.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 56.22%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $758.75 6.61%
CH